Johnson & Johnson EV/Sales
¿Qué es el EV/Sales de Johnson & Johnson?
El EV/Sales de Johnson & Johnson es 5.93
¿Cuál es la definición de EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales de compañías en Sector Health Care en NYSE en comparadas con Johnson & Johnson
¿Qué hace Johnson & Johnson?
Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods.
Empresas con ev/sales similar a Johnson & Johnson
- Paramount Inc tiene EV/Sales de 5.92
- Mcphy S.A. Eo 0,12 tiene EV/Sales de 5.92
- Crossword Cybersecurity Plc tiene EV/Sales de 5.92
- iShares € Corp Bond 0-3yr ESG UCITS ETF EUR (Dist) tiene EV/Sales de 5.93
- Budweiser Brewing APAC tiene EV/Sales de 5.93
- Vixtel Technologies tiene EV/Sales de 5.93
- Johnson & Johnson tiene EV/Sales de 5.93
- ASM International NV tiene EV/Sales de 5.94
- SiteMinder tiene EV/Sales de 5.94
- Aon plc tiene EV/Sales de 5.94
- Atlas tiene EV/Sales de 5.94
- Housing Development Finance tiene EV/Sales de 5.94
- Avid Bioservices Inc tiene EV/Sales de 5.94